Tanghetti E - Search Results

1

Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne.

Blume-Peytavi U, Fowler J, Kemény L, Draelos Z, Cook-Bolden F, Dirschka T, Eichenfield L, Graeber M, Ahmad F, Alió Saenz A, Rich P, Tanghetti E. Blume-Peytavi U, et al. Among authors: tanghetti e. J Eur Acad Dermatol Venereol. 2020 Jan;34(1):166-173. doi: 10.1111/jdv.15794. Epub 2019 Aug 20. J Eur Acad Dermatol Venereol. 2020. PMID: 31306527 Free PMC article. Clinical Trial.

2

Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy.

Draelos ZD, Tanghetti EA; Tazarotene Combination Leads to Efficacious Acne Results (CLEAR) Trial Study Group. Draelos ZD, et al. Cutis. 2002 Feb;69(2 Suppl):20-9. Cutis. 2002. PMID: 12095065 Clinical Trial.

3

Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized study.

Lowe N, Horwitz S, Tanghetti E, Draelos Z, Menter A. Lowe N, et al. Among authors: tanghetti e. J Cosmet Laser Ther. 2006 Sep;8(3):121-7. doi: 10.1080/14764170600895237. J Cosmet Laser Ther. 2006. PMID: 16971360 Clinical Trial.

4

Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.

Bikowski J, Callender VD, Del Rosso JQ, Draelos ZD, Tanghetti E. Bikowski J, et al. Among authors: tanghetti e. Cutis. 2006 Aug;78(2 Suppl 1):13-20. Cutis. 2006. PMID: 17966495

5

Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.

Tanghetti E, Dhawan S, Torok H, Kircik L. Tanghetti E, et al. Dermatol Online J. 2007 Jul 13;13(3):1. Dermatol Online J. 2007. PMID: 18328195 Clinical Trial.

6

Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.

Tanghetti E, Kircik L, Wilson D, Dhawan S. Tanghetti E, et al. J Drugs Dermatol. 2008 Jun;7(6):534-8. J Drugs Dermatol. 2008. PMID: 18561583 Clinical Trial.

7

A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide.

Thiboutot D, Eichenfield L, Shalita A, Del Rosso JQ, Swinyer L, Tanghetti E, Tschen E, Parr L. Thiboutot D, et al. Among authors: tanghetti e. Cutis. 2009 Jul;84(1):48-55. Cutis. 2009. PMID: 19743725 Clinical Trial.

8

Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.

Tanghetti E, Dhawan S, Green L, Del Rosso J, Draelos Z, Leyden J, Shalita A, Glaser DA, Grimes P, Webster G, Barnett P, Le Gall N. Tanghetti E, et al. J Drugs Dermatol. 2010 May;9(5):549-58. J Drugs Dermatol. 2010. PMID: 20480800 Clinical Trial.

9

Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.

Tanghetti E, Dhawan S, Green L, Ling M, Downie J, Germain MA, Kasteler JS, Kircik L, Oefelein MG, Draelos Z. Tanghetti E, et al. J Drugs Dermatol. 2011 Jul;10(7):783-92. J Drugs Dermatol. 2011. PMID: 21720661 Clinical Trial.

10

The noncompliant patient with acne.

Tanghetti EA. Tanghetti EA. Skin Therapy Lett. 2011 Nov-Dec;16(10):4-5. Skin Therapy Lett. 2011. PMID: 22337078 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters